Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by houbahopon Mar 14, 2022 4:21pm
121 Views
Post# 34512987

RE:RE:RE:RE:MTD

RE:RE:RE:RE:MTDYou are confronting TH neurotic culture.
They've been told for decades by their shareholders.
And they are still in denial.

No wonder there are no changes in the communications with their shareholders.

Management has the privilege of having a straight forward communication with a major shareholder telling them:

8/ " ... very loudly and as obnoxiously as I could to make sure the message was not missed that their interaction with the investment comunity is a five alarm fire that needs to be addressed yesterday or earlier. Unfortuately, I did not get any indication that they see it as a huge problem, so that remains disconcerting to say the least."

And TH CEO's reply is: Naaah... we don't see this as a problem....
Paul as been gobbled up by TH's corporate culture. He's now here for the pay check with no palatable results, like the others. Sad.

LOL!
<< Previous
Bullboard Posts
Next >>